CRYZL2P

Across TCGA pan-cancer cohorts, CRYZL2P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated CRYZL2P data layer compared with 2 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CRYZL2P RNA is associated with better overall survival. In most high-consensus cancer types, elevated CRYZL2P expression acts as an unfavorable survival marker, although some lineages such as KIRC and KIRP show a favorable association.

KIRC, KIRP, and LGG are the cancer types where CRYZL2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.911	0.834	<.001	63	view →
KIRP	DFS	Median	II,III,IV	0.939	0.486	.005	47	view →
LGG	DFS	Median	All	0.653	0.813	<.001	45	view →
UVM	OS	Median	III,IV	0.240	0.836	.001	37	view →
BLCA	DFS	Tertile	All	0.265	0.592	.001	27	view →
ESCA	OS	Median	All	0.418	1.000	.005	18	view →
SARC	OS	Tertile	All	0.912	0.776	.003	14	view →
GBM	DFS	Quartile	All	0.203	0.360	.009	11	view →
KICH	DFS	Median	All	1.000	0.763	.023	10	view →
LUAD	OS	Median	All	0.275	0.437	.022	10	view →
CHOL	DFS	Tertile	III,IV	0.172	0.779	.024	9	view →
COAD	OS	Tertile	IV	0.190	0.866	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

CRYZL2P–KIRC (OS)

Open the KIRC breakdown →